Recent Updates
Recently added Catalysts
BBIO

Eidos Therapeutics Announces Closing Of Initial Public Offering And Exercise In Full Of The Underwriters' Option To Purchase Additional Shares

Key Takeaway: Eidos Therapeutics Announces Closing Of Initial Public Offering And Exercise In Full Of The Underwriters' Option To Purchase Additional Shares

Full Press Release Details

Eidos Therapeutics Announces Closing Of Initial Public Offering And Exercise In Full Of The Underwriters' Option To Purchase Additional Shares.
Last updated: Jun 22, 2018